Congressional Research Service Reports - 81 Matching Results
Search Results
- War on Drugs: The National Youth Anti-Drug Media Campaign
- This report discusses the authorization of the National Youth Anti-Drug Media Campaign, a multi-media federal program to persuade America's youth not to use drugs, which expired at the end of FY2002. H.R. 2829 (passed by the House on March 13, 2006) and S. 2560 (reported by the Senate Judiciary Committee on May 25, 2006) would reauthorize the media campaign, along with the other programs run by the Office of National Drug Control Policy (ONDCP) during FY2007.
- High Intensity Drug Trafficking Areas (HIDTA) Program
- This report provides an overview of the High Intensity Drug Trafficking Areas (HIDTA) program, including how areas are designated as part of a HIDTA, and program coordination and funding. It also examines issues that policymakers may consider as they debate the future of the program: whether the county is still an appropriate unit of inclusion, whether the criteria remain adequate, whether the program is effective, whether its tangential effects can be measured, whether the current bounds on funds are still appropriate, and which federal entity may be best suited to administer the program.
- Prescription Drug Abuse
- This report examines prescription drug abuse in the United States. An estimated 6.8 million individuals currently abuse prescription drugs in the United States. Unlike policy on street drugs, federal policy on prescription drug abuse is complicated by the need to maintain access to prescription controlled substances (PCS) for legitimate medical use. The federal government has several roles in reducing prescription drug abuse.
- Federal Drug Control: President's Budget Request for Fiscal Year 1988
- This report discusses the President's FY1988 budget, focusing on the $3 billion set aside for Federal programs to control or prevent the use of narcotics and other dangerous drugs. The report includes various key documents illustrating the positions taken by Congressional critics of the request as well as the Administration's defenses. Finally, for a longer term perspective, there are graphs and a table showing drug budget trends since FY 1981.
- Federal Drug Control: President's Budget Request for Fiscal Year 1988
- This report discusses the President's FY1988 budget, focusing on the $3 billion set aside for Federal programs to control or prevent the use of narcotics and other dangerous drugs. The report includes various key documents illustrating the positions taken by Congressional critics of the request as well as the Administration's defenses. Finally, for a longer term perspective, there are graphs and a table showing drug budget trends since FY 1981.
- Control of Drug Abuse : Summary of Principal Legislative Activity in the 93rd Congress
- This report collects Federal government efforts to control drug abuse in the United States.
- Drug Abuse in the Military: Selected References 1970-1972
- This bibliography collects published works on drug abuse in the United States Military published from 1970 to 1972.
- Marijuana: Medical and Retail -- An Abbreviated View of Selected Legal Issues
- This report discusses the federal law regarding marijuana that is classified as a Schedule I Controlled Substance. The federal Controlled Substances Act (CSA) outlaws the possession, cultivation, or distribution of marijuana except for authorized research.
- Marijuana: Medical and Retail -- Selected Legal Issues
- This report discusses state medical marijuana laws that grants registered patients, their doctors, and providers immunity from the consequences of state law.
- Active Opioid Legislation in the House: In Brief
- This report briefly summarizes opioid-related bills that were considered during "Opioid Week" (the week of May 9, 2016) The summaries in this report may be useful illustrations of the range of approaches Members of Congress have proposed to address the problem of opioid addiction.
- Marijuana: Medical and Retail-- Selected Legal Issues
- This report discusses the federal Controlled Substances Act (CSA) as it pertains to marijuana. The CSA outlaws the possession, cultivation, and distribution of marijuana except for authorized research. More than 20 states have regulatory schemes that allow possession, cultivation, and distribution of marijuana for medicinal purposes. The U.S. Constitution's Supremacy Clause preempts any state law that conflicts with federal law.
- Drug Abuse and Minority Groups in the United States: Selected References
- This bibliography is a collection of published works concerning minority groups and drug abuse in the United States.
- Legislation Relating to the Control of Drug Abuse, 92nd Congress
- This report
- The Marijuana Policy Gap and the Path Forward
- This report describes the federal response to state actions to decriminalize or legalize marijuana. It includes general information about marajuana and trends among states, the federal response, a discussion of the implications of legalization, and selected issues.
- Constitutional Analysis of Suspicionless Drug Testing Requirements for the Receipt of Governmental Benefits
- This report gives an overview of the issues related to federal or state laws that condition the initial or ongoing receipt of governmental benefits on passing drug tests. These regulations are vulnerable to constitutional challenge, most often due to issues of personal privacy and Fourth Amendment protections against "unreasonable searches."
- The SUPPORT for Patients and Communities Act (P.L. 115-271): Food and Drug Administration and Controlled Substance Provisions
- This report summarizes the provisions in Title III--the FDA (Food and Drug Administration) and Controlled Substance Provisions, as well as Section 4004 "Modernizing the Reporting Requirements of Biological and Biosimilar Products" in Title IV--Offsets.
- 2016 Rio Games: Anti-Doping Testing
- This report discusses the the anti-doping testing program during the 2016 Summer Olympics. Responsibility for the rests with the International Olympic Committee (IOC). The testing period began July 24, 2016, when the Olympic village opened, and continues through August 21, 2016, the date of the closing ceremony.
- Constitutional Analysis of Suspicionless Drug Testing Requirements for the Receipt of Governmental Benefits
- This report provides an overview of the Fourth Amendment in order to effectively evaluate the constitutionality of laws requiring suspicionless drug tests to receive governmental benefits. It then reviews five Supreme Court decisions that have evaluated these programs. The report concludes with a synthesis of the various factors that likely will be important to a future court's assessment of the constitutionality of these laws.
- Methamphetamine: Legislation and Issues in the 109th Congress
- This report provides a brief overview of illicit methamphetamine (MA) abuse, production, trafficking, the federal methamphetamine-specific programs, and anti-MA legislation introduced in the 109th Congress. MA abuse has implications for public health, child welfare, crime and public safety, border security, and international relations.
- Heroin Trafficking in the United States
- This report provides an overview of heroin trafficking into and within the United States. It includes a discussion of links between the trafficking of heroin and the illicit movement of related substances such as controlled prescription drugs and synthetic drugs like fentanyl. The report also outlines existing U.S. efforts to combat heroin trafficking and possible congressional considerations going forward.
- Constitutional Analysis of Suspicionless Drug Testing Requirements for the Receipt of Governmental Benefits
- This report gives an overview of the issues related to federal or state laws that condition the initial or ongoing receipt of governmental benefits on passing drug tests. These regulations are vulnerable to constitutional challenge, most often due to issues of personal privacy and Fourth Amendment protections against "unreasonable searches."
- Reauthorizing the Office of National Drug Control Policy: Issues for Consideration
- Report discussing the National Drug Control Strategy, the National Drug Control Budget, and the Office of National Drug Control Policy's (ONDCP) evaluation of the National Drug Control Strategy implementation. It also provides an analysis of selected legislative and oversight issues that Congress may consider when debating the reauthorization of ONDCP.
- Prescription Drug Monitoring Programs
- This report looks at ways that prescription drug monitoring programs (PDMPs), which maintain statewide electronic databases of prescriptions dispensed for controlled substances, can help to deter prescription drug misuse.
- Increase in Illicit Fentanyl Overdose Deaths
- This report discusses fentanyl, a synthetic opioid that is 50-100 times more potent than morphine. The steep increase in overdose deaths involving fentanyl is seen as a "new chapter" in the opioid epidemic. Topics covered include the rise of fentanyl overdoses, availability of fentanyl, and policy considerations.
- The Opioid Epidemic and the Food and Drug Administration: Legal Authorities and Recent Agency Action
- This report focuses on the U.S. Food and Drug Administration (FDA) as a key player in federal efforts to curb the opioid epidemic. It provides an overview of FDA's role in approving new prescription drugs, including challenges of approval and regulation of opioid products; addresses FDA's multifaceted approach in responding, including recent agency action; and concludes with a discussion of selected opioid-related legislation in the 115th Congress.
- Prescription Drug Monitoring Programs
- This report looks at ways that prescription drug monitoring programs (PDMPs), which maintain statewide electronic databases of prescriptions dispensed for controlled substances, can help to deter prescription drug misuse.
- Methadone Maintenance Treatment for Heroin Addiction
- This report discusses methadone treatment centers for heroin addicts and research regarding their successes and limitations.
- The World Drug Problem: UNGA Convenes for a Special Session
- This report discusses the U.N. special session on the problem of drug abuse in the world. The interests and outcomes of the U.S. and U.N are also discussed.
- Heroin: Legalization for Medical Use
- This report discusses the limited legalization of diacetylmorphine (heroin) for use in the medical treatment of intractable pain. The report attempts to present pros and cons on the issue as well as information on pending legislation. The report also provides a comparison of heroin's analgesic qualities to those of currently available and equivalent pharmaceutical alternatives.
- Federal Laws Relating to the Control of Narcotics and Other Dangerous Drugs, Enacted 1961-1985: Brief Summaries
- This report contains summaries of enactments, treaties, and reorganization plans, passed from 1961 through 1985, that have some clearly indicated relationship-- either by specific reference or by virtue of legislative history--to the Federal effort to prevent drug misuse through control of the supply of narcotics and other dangerous drugs.
- Drug Testing and Crime-Related Restrictions in TANF, SNAP, and Housing Assistance
- Report that describes and compares the drug- and crime-related policy restrictions contained in selected federal programs that provide assistance to low-income individuals and families: the Temporary Assistance for Needy Families (TANF) block grant, the Supplemental Nutrition Assistance Program (SNAP, formerly Food Stamps), and the three primary federal housing assistance programs (the public housing program, the Section 8 Housing Choice Voucher program, and the project-based Section 8 rental assistance program).
- Legal Issues Relating to the Disposal of Dispensed Controlled Substances
- Prescription drug abuse is the second-most common form of illicit drug abuse among teenagers in the United States, trailing only marijuana use. Prescription drug abuse has become a particular concern amongst federal policymakers. This report discusses this issue, including related pieces of legislation such as the Controlled Substances Act, the Secure and Responsible Drug Disposal Act of 2010, and the proper way to dispose of controlled substances.
- Legal Issues Relating to the Disposal of Dispensed Controlled Substances
- This report describes an issue that is the fastest-growing drug problem in the country -- the intentional use of prescription drugs for non-medical purposes. It is the second-most common form of illicit drug abuse among teenagers in the United States behind marijuana use. Several bills have been introduced in the 111th Congress that would create a legal framework governing disposal of controlled substances that have been dispensed to patients.
- War on Drugs: Reauthorization of the Office of National Drug Control Policy
- This report discusses the Office of National Drug Control Policy Reauthorization Act of 2005 , which would reauthorize ONDCP for five years, through FY2010, and authorize funding in specific annual amounts for the High Intensity Drug Trafficking Area (HIDTA) Program, the media campaign, a Southwest Border violence study, and several anti-methamphetamine initiatives.
- The World Drug Problem: UNGA Convenes for a Special Session
- This report briefly discusses the United Nations General Assembly's (UNGA) 2016 special session on "The World Drug Problem." It is the third time the UNGA will convene such a session on global drug issues.
- Buprenorphine and the Opioid Crisis: A Primer for Congress
- This report addresses questions policymakers may have about the effectiveness of the opioid addiction treatment drug buprenorphine, the demand for buprenorphine, and access to buprenorphine.
- Substance Abuse Prevention, Treatment, and Research Efforts in the Military
- This report discusses substance abuse trends in the military, efforts by the U.S. Department of Defense (DOD) to address the opioid crisis, and the main elements of DOD's substance abuse prevention, compliance, and disciplinary policies.
- The World Drug Problem: UNGA Convenes for a Special Session
- This report briefly discusses the United Nations General Assembly (UNGA), which has convened in New York for a special session on "The World Drug Problem." It is the third time the UNGA will convene such a session on global drug issues. Previous special sessions on drugs were held in 1990 and 1998.
- The Comprehensive Addiction and Recovery Act of 2016 (S. 524): Comparison of Senate- and House-Passed Versions
- This report discusses selected differences and similarities between the Senate- and House-passed versions of the Comprehensive Addiction and Recovery Act of 2016 (CARA; S. 524), which aims to address the problem of opioid addiction in the United States. The two versions of the bill differ substantially. The scope of the differences may be illustrated by their structures: The Senate bill has 28 sections organized in 8 titles, whereas the House bill has 69 sections organized in 18 titles.
- Legal Authorities Under the Controlled Substances Act to Combat the Opioid Crisis
- This report discusses legal authorities available to the federal government under the Controlled Substances Act (CSA) that could be used to combat the opioid epidemic. The report then examines DEA initiatives and actions taken, pursuant to its legal authorities under the CSA, which specifically target the abuse of opioids. It concludes by discussing selected opioid-related legislative proposals in the 115th Congress that would amend the CSA.
- Opioid Treatment Programs and Related Federal Regulations
- This report provides information on federal regulations regarding treatment for opioid addiction, including medication-assisted treatment (MAT), opioid treatment programs (OTPs), and DATA-waived providers (DWPs).
- Drug Offenses: Maximum Fines and Terms of Imprisonment for Violation of the Federal Controlled Substances Act and Related Laws
- This is a chart of the maximum fines and terms of imprisonment that may be imposed as a consequence of conviction for violation of the federal Controlled Substances Act (CSA) and other drug supply and drug demand related laws. It lists the penalties for: heroin, cocaine, crack, PCP, LSD, marihuana (marijuana), amphetamine, methamphetamine, listed (precursor) chemicals, paraphernalia, date rape drugs, rave drugs, designer drugs, ecstasy, drug kingpins, as well as the other substances including narcotics and opiates assigned to Schedule I, Schedule II, Schedule III, Schedule IV, and Schedule V of the Controlled Substances Act and the Controlled Substances Import and Export Act (Title II and Title III of the Comprehensive Drug Abuse and Control Act).
- Drug Offenses: Maximum Fines and Terms of Imprisonment for Violation of the Federal Controlled Substances Act and Related Laws
- This report is a chart of the maximum fines and terms of imprisonment that may be imposed as a consequence of conviction for violation of the federal Controlled Substances Act (CSA) and other drug supply and drug demand related laws.
- Drug Testing and Crime-Related Restrictions in TANF, SNAP, and Housing Assistance
- This report describes and compares the drug- and crime-related policy restrictions contained in selected federal programs that provide assistance to low-income individuals and families: the Temporary Assistance for Needy Families (TANF) block grant, the Supplemental Nutrition Assistance Program (SNAP, formerly Food Stamps), and the three primary federal housing assistance programs (the public housing program, the Section 8 Housing Choice Voucher program, and the project-based Section 8 rental assistance program).
- Drug Control: International Policy and Approaches
- This report discusses various U.S. international narcotics policy approaches meant to achieve two main goals: to reduce the supply of illicit narcotics flowing into the United States, and to reduce the amount of illicit narcotics cultivated, processed, and consumed worldwide.
- Federal Cocaine Sentencing Disparity: Sentencing Guidelines, Jurisprudence, and Legislation
- This report discusses legislation and several court cases to examine the changing nature of Crack Cocaine penalties in comparison to powder cocaine. Until 2005, the Guidelines were binding on federal courts: the judge had discretion to sentence a defendant, but only within the narrow sentencing range that the Guidelines provided. In its 2005 opinion United States v. Booker, the Supreme Court declared that the Guidelines must be considered advisory rather than mandatory, in order to comply with the Constitution. Instead of being bound by the Guidelines, sentencing courts must treat the federal guidelines as just one of a number of sentencing factors (which include the need to avoid undue sentencing disparity).
- International Drug Control Policy
- This report discusses the scope of the international drug control problem, current measures in place. It includes sections that discuss: the global scope of the problem, strategic guidance, overall U.S. drug control funding, U.S. assistance for international counternarcotics programs, policy issues, and conclusions.
- Responding to the Opioid Epidemic: Legal Developments and FDA's Role
- This report discusses the opioid epidemic in the U.S. and the role of the Federal Food and Drug Administration (FDA) in helping end the epidemic. The report provides an overview of FDA's existing authorities, the historical context for the opioid epidemic, and the agency's current plan for combatting the opioid epidemic, concluding with an examination of the broader legal questions concerning the crisis.
- Federal Support for Drug Courts: In Brief
- This report explains the concept of a "drug court,", how the term and programs have expanded to include wider meanings and serve additional subgroups, how the federal government supports drug courts, and research on the impact of drug courts on offenders and court systems. In addition, it briefly discusses how drug courts might provide an avenue for addressing the opioid epidemic and other emerging drug issues that Congress may consider.
- International Drug Control Policy
- This report provides an overview of U.S. international drug control policy. It describes major international counternarcotics initiatives and evaluates the broad array of U.S. drug control policy tools currently in use. The report also considers alternative counterdrug policy approaches to current initiatives and raises several counterdrug policy issues and considerations for policy makers.